ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors With Losses of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD, ADGI) between November 29, 2021 and December 14, 2021, both dates inclusive (the “Class Period”) of the important